2-238251757-T-A
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_022817.3(PER2):c.3116A>T(p.Asp1039Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/24 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1039G) has been classified as Uncertain significance.
Frequency
Consequence
NM_022817.3 missense
Scores
Clinical Significance
Conservation
Publications
- advanced sleep phase syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- advanced sleep phase syndrome 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022817.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PER2 | TSL:1 MANE Select | c.3116A>T | p.Asp1039Val | missense | Exon 20 of 23 | ENSP00000254657.3 | O15055-1 | ||
| PER2 | c.3116A>T | p.Asp1039Val | missense | Exon 20 of 23 | ENSP00000516757.1 | O15055-1 | |||
| PER2 | c.3116A>T | p.Asp1039Val | missense | Exon 20 of 23 | ENSP00000516758.1 | O15055-1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 31
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at